M&As this week: Tiansheng Pharmaceutical Group, Skyline Medical
Pharmaceutical company Tiansheng Pharmaceutical Group Co Ltd plans to acquire 51% stake in medical device company Hubei Xianming Medical Devices Co Ltd for CNY5.1m ($0.76m).
Both the acquirer and target companies are based in China.
Medical waste management technology provider Skyline Medical Inc has announced plans to merge with CytoBioscience, a developer of medical instruments for disease analysis and treatment.
Both the companies involved in the merger are based in the US.